EUVIMEDEUVIMED entdecken
Crossref

Lacrimal sac squamous cell carcinoma: diagnostic challenges, surgical management and clinical outcomes

Paula Niinimäki, Caj Haglund, Hagström Jaana, Jyrki Vuola, Olli Tynninen, Aaro Haapaniemi, Antti Mäkitie, Tero T Kivelä, Marita Uusitalo

Orbit · 2026

DOI: 10.1080/01676830.2026.2664745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Orbit, 2026. Verfasst von Paula Niinimäki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Eye Neoplasms, Lacrimal Apparatus Diseases. Die Arbeit nennt 27 Literaturangaben. Gefördert von: The Eye Foundation, The Eye and Tissue Bank Foundation, The Mary and Georg C. Ehrnrooth Foundation and Helsinki University Hospital Research Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the incidence, clinical features, diagnostic challenges, patient and healthcare-related delays, management, and outcomes of lacrimal sac squamous cell carcinoma (lsSCC) at a tertiary care centre. METHODS: We identified patients from the Finnish Cancer Registry and the Helsinki University Hospital (HUS, Helsinki, Finland) databases over a 16-year period 2007-2022 and analysed clinical features, histopathology, human papillomavirus (HPV) positivity by immunohistochemical staining for p16INK4A (p16) and mRNA detection by in situ hybridization for high-risk HPV (HR-HPV), and treatment. RESULTS: The median age at diagnosis for the 13 patients was 67 years (range, 40-97). Median time to histopathologic diagnosis of lsSCC was 6 months (range, 0-36). The most common reason for delay was treatment based on an incorrect diagnosis of dacryocystitis. Eye-sparing surgery was performed in eight (62%) and exenteration in five (38%) patients. Differentiation was classified as grade 2 in 38% and grade 3 in 62% of tumours. Eight of 12 analysed tumours (67%) were HPV positive. The reconstruction method involved a microvascular flap in 54% and a local pedicular skin or fascia flap in 46% of patients. Ten patients received postoperative external beam radiotherapy, and one patient received chemotherapy. The median follow-up time was 5 years (range, 0-17). The patient with regional micrometastasis developed systemic metastatic disease at 11 months and died of metastatic lsSCC 22 months after surgery. CONCLUSION: Two-thirds of the patients had an HR-HPV-positive tumour. Diagnosis of lsSCC is often delayed. Despite high tumour grade, recurrences and metastasis of lsSCC were rare in this cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellEye NeoplasmsLacrimal Apparatus DiseasesHumansFemaleAgedMaleMiddle AgedAdultAged, 80 and overFinlandImmunohistochemistryHuman Papillomavirus VirusesIn Situ HybridizationPapillomavirus InfectionsIncidenceTreatment OutcomeOphthalmologic Surgical ProceduresCyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

differential diagnosis of dacryocystitisexenterationeye sparing surgerylacrimal sac tumourp16

Substanzen

Cyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Department of Ophthalmology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, Helsinki, Finland.
  • Department of Oral Pathology and Radiology, University of Turku, Turku, Finland.
  • Department of Plastic Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Department of Pathology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Förderung

  • The Eye Foundation, The Eye and Tissue Bank Foundation, The Mary and Georg C. Ehrnrooth Foundation and Helsinki University Hospital Research Funds

Zitieren

APA

Niinimäki, P., Haglund, C., Jaana, H., Vuola, J., Tynninen, O., Haapaniemi, A., Mäkitie, A., Kivelä, T. T., & Uusitalo, M. (2026). Lacrimal sac squamous cell carcinoma: diagnostic challenges, surgical management and clinical outcomes. Orbit. https://doi.org/10.1080/01676830.2026.2664745

Vancouver

Niinimäki P, Haglund C, Jaana H, Vuola J, Tynninen O, Haapaniemi A, et al. Lacrimal sac squamous cell carcinoma: diagnostic challenges, surgical management and clinical outcomes. Orbit. 2026. doi:10.1080/01676830.2026.2664745

BibTeX
@article{Niinimki2026,
  author = {Niinimäki, Paula and Haglund, Caj and Jaana, Hagström and Vuola, Jyrki and Tynninen, Olli and Haapaniemi, Aaro and Mäkitie, Antti and Kivelä, Tero T and Uusitalo, Marita},
  title = {Lacrimal sac squamous cell carcinoma: diagnostic challenges, surgical management and clinical outcomes},
  journal = {Orbit},
  year = {2026},
  doi = {10.1080/01676830.2026.2664745}
}
Kostenlos starten →